Cargando…
Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects
Glioblastoma (GBM) is the most common primary brain neoplasm with median overall survival (OS) around 15 months. There is a dearth of effective monitoring strategies for patients with high-grade gliomas. Relying on magnetic resonance images of brain has its challenges, and repeated brain biopsies ad...
Autores principales: | Hafeez, Umbreen, Cher, Lawrence M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212884/ https://www.ncbi.nlm.nih.gov/pubmed/32642651 http://dx.doi.org/10.1093/noajnl/vdz013 |
Ejemplares similares
-
Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma
por: Balasubramanian, Adithya, et al.
Publicado: (2020) -
Intracranial Undifferentiated Sarcoma Arising from a Low-Grade Glioma: A Case Report and Literature Review
por: Kim, Bum-Joon, et al.
Publicado: (2015) -
Back to the future--radiotherapy in high grade gliomas.
por: Brada, M.
Publicado: (1989) -
Modeling of intracranial tumor treating fields for the treatment of complex high-grade gliomas
por: Segar, David J., et al.
Publicado: (2023) -
Smart Monitoring and Control in the Future Internet of Things
por: Cicirelli, Franco, et al.
Publicado: (2021)